Nav: Home

How are dreaded multidrug-resistant pathogens brought into hospitals?

August 17, 2016

According to National Reference Center for Surveillance of Nosocomial Infections esti-mates, up to 15,000 patients die of hospital-acquired infections in Germany every year. Here, multidrug-resistant bacteria, against which common antibiotics are no longer effec-tive, play a major role. But where do these pathogens come from? In largest study of its kind in Europe, DZIF scientists from the University of Cologne investigated this question and discovered that almost ten percent of patients admitted into hospitals already bring these dreaded pathogens along with them from home.

"We were surprised that on hospital admission almost every tenth patient is colonised with multidrug-resistant pathogens," explains Dr Axel Hamprecht from the University of Cologne. He coordinated this study, in which six German university hospitals participated, together with Prof Harald Seifert, also from the University of Cologne, and colleagues from Charité Berlin. Over 4,000 adults were tested for multidrug-resistant Enterobacteriaceae on admission into hospital by means of stool samples or rectal swabs.

Enterobacteriaceae such as Escherichia coli constitute a normal part of the gut flora and are not pathogenic--as long as they remain in the gut. However, they can cause infections in oth-er organs, for example urinary tract infections. An infection caused by multidrug-resistant bacteria is much more difficult to treat and requires the use of last-resort antibiotics. In their investigations, the researchers paid particular attention to a group of multidrug-resistant bacte-ria that are often problematic in hospitals: so-called third-generation cephalosporin-resistant Enterobacteriaceae (3GCREB).

These multidrug-resistant gut bacteria which are resistant to cephalosporins, amongst other drugs, have spread worldwide over the past years. Similar to penicillin, cephalosporins are antibiotics that kill bacteria by inhibiting bacterial cell wall synthesis. Newer third-generation cephalosporins are effective against a broad spectrum of bacteria and belong to the group of most commonly used antibiotics. However, over the course of time, the bacteria have defend-ed themselves and have acquired so-called beta-lactamase--an enzyme that renders these an-tibiotics ineffective. Enterobacteriaceae are transmitted by smear infection, predominantly via faeces and food.

Every tenth patient brings the pathogens into hospital

Out of the 4,376 adults who were tested for 3GCREB pathogens on admission to one of the participating hospitals, 416 were carriers of these multidrug-resistant pathogens. This preva-lence is higher than has previously been reported in Germany. Especially often, the scientists found beta-lactamase producing Escherichia coli bacteria, so-called ESBL-producing Entero-bacteriaceae. The prevalence of these multidrug-resistant pathogens differed from hospital to hospital.

In order to elucidate the factors for colonisation with these bacteria, the patients completed a questionnaire on previous hospital stays and lifestyle habits. "Patients who have taken antibi-otics and travellers outside Europe are at higher risk," says Hamprecht, underlining two im-portant research findings.

Experts recommend more hygiene and using fewer antibiotics

What can be done to prevent the spread of multidrug-resistant pathogens as early as possible? Hamprecht is certain, "With so many people affected, the strategy of isolating patients within the hospitals no longer works. Additionally, in contrast to other groups of multidrug-resistant bacteria such as MRSA (Methicillin-resistant Staphylococcus-aureus) strains, standardised sanitation measures for 3GCREB have not been established." Instead, Hamprecht and Seifert recommend improving hygiene measures in hospitals and practices, a rational use of antibiotics and especially reducing their non-justified administration, as well as more training for doctors.
-end-
The study was conducted as part of the antibiotic therapy optimisation study (ATHOS). Fur-ther participating centres are the Charité - Universitätsmedizin Berlin, as well as the Universi-ty Hospitals of Freiburg, Lübeck, Munich and Tübingen.

Publication

A Hamprecht, A M Rohde, M Behnke, S Feihl, P Gastmeier, F Gebhardt, W V Kern, J K Knobloch, A Mischnik, B Obermann, C Querbach, S Peter, C Schneider, W Schröder, F Schwab, E Tacconelli, M Wiese-Posselt, T Wille, M Willmann, H Seifert, J Zweigner; on be-half of the DZIF ATHOS Study Group

Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors.

J Antimicrob Chemother 2016 Jun 17. Epub 2016 Jun 17. Doi:10.1093/jac/dkw216

Contact

Dr Axel Hamprecht
University of Cologne
DZIF research field "Healthcare-associated and Antibiotic-resistant bacterial Infections"
T: +49 221 478 -32162/-32100
E-Mail: axel.hamprecht@uk-koeln.de

Prof Harald Seifert
University of Cologne
DZIF research field "Healthcare-associated and Antibiotic-resistant bacterial Infections"
T: +49 221 478-32009
E-Mail: harald.seifert@uni-koeln.de

German Center for Infection Research

Related Bacteria Articles:

Conducting shell for bacteria
Under anaerobic conditions, certain bacteria can produce electricity. This behavior can be exploited in microbial fuel cells, with a special focus on wastewater treatment schemes.
Controlling bacteria's necessary evil
Until now, scientists have only had a murky understanding of how these relationships arise.
Bacteria take a deadly risk to survive
Bacteria need mutations -- changes in their DNA code -- to survive under difficult circumstances.
How bacteria hunt other bacteria
A bacterial species that hunts other bacteria has attracted interest as a potential antibiotic, but exactly how this predator tracks down its prey has not been clear.
Chlamydia: How bacteria take over control
To survive in human cells, chlamydiae have a lot of tricks in store.
Stress may protect -- at least in bacteria
Antibiotics harm bacteria and stress them. Trimethoprim, an antibiotic, inhibits the growth of the bacterium Escherichia coli and induces a stress response.
'Pulling' bacteria out of blood
Magnets instead of antibiotics could provide a possible new treatment method for blood infection.
New findings detail how beneficial bacteria in the nose suppress pathogenic bacteria
Staphylococcus aureus is a common colonizer of the human body.
Understanding your bacteria
New insight into bacterial cell division could lead to advancements in the fight against harmful bacteria.
Bacteria are individualists
Cells respond differently to lack of nutrients.

Related Bacteria Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...